As a control, spatial transcriptomic analyses of a section of normal liver from a patient with hepatoblastoma showed very low expression of FGF19, AXIN2, and SOX4, without apparent co-localization (Supplementary Fig. S1f). Here, FGF19 is linked to hepatoblastoma.